MedPath

Effect of Ayurvedic treatment in chronic simple rhinitis

Phase 2/3
Completed
Conditions
Chronic rhinitis,
Registration Number
CTRI/2020/12/029618
Lead Sponsor
Sane Guruji Arogya Kendra
Brief Summary

This study is open labelled randomized controlled clinical trial toevaluate the effect of Nidigdhikadi Kwatha daily orally once in a day for 21daysin comparison with Tab Levocetrizine 5mg in combination with Phenylephrine 10mgat night in patients affected with Peenasa Vyadhi w.r.t Chronic Simple Rhinitis.The Primary outcome will be effect of Nidigdhikadi Kwatha and the secondaryoutcome will be comparison between trial drug and control drug in management ofPeenasa Vyadhi w.r.t Chronic Simple Rhinitis

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
74
Inclusion Criteria
    1. Patients fulfilling the diagnostic criteria of Peenasa(Chronic Simple Rhinitis).
    1. Patients suffering from three or more the following symptoms for more than one months were selected for study.( Nasal obstruction, Nasal discharge, Headache , Swollen turbinate’s, Post-Nasal discharge ) 3) A patients having age group 18 to 60 years.
    1. Patient willing to participate in the study.
    1. Patients were recruited irrespective of sex, religion, occupation.
Exclusion Criteria
    1. Pregnant women and Children.
    1. Patients with history of congenital disorder of Nose.
    1. Patients suffering from gross deviation of nasal septum and associated with other nasal pathology like nasal polyp etc.
    1. Patients with uncontrolled systemic diseases like Diabetes Mellitus and Hypertension.
    1. Chronic simple Rhinitis associated with Hyperthyroidism, Exanthemas, Adenoidal Hyperplasia, Choanal Atresia and Nasal Tumors.
    1. Patient having Angle-Closure Glaucoma and Pyloric Stenosis.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Primary outcome will be evaluation of efficacy of Nidigdhikadi Kwatha in Peenasa Vyadhi w.r.t Chronic Simple RhinitisThe drug will be given for 21 days.The efficacy will be assessed on the basis of VAS SCALE for symptoms before and after treatment. The patients will be assessed before and after treatment. Total duration of the study will 18 months.
Secondary Outcome Measures
NameTimeMethod
A comparison between efficacyof Nidigdhikadi Kwatha and Tab Levocetrizine 5mg

Trial Locations

Locations (1)

Sane Guruji Arogya Kendra

🇮🇳

Pune, MAHARASHTRA, India

Sane Guruji Arogya Kendra
🇮🇳Pune, MAHARASHTRA, India
Vd Sandip Patil
Principal investigator
8379890248
patilsandip771@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.